david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation....pm.
he said: "greater and immediate attention needs to be applied in these two areas.".may 17, 2018, 4:08pm edt.. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..